FDA Approved: ICATIBANT — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma's generic icatibant under ANDA211021 for the treatment of acute attacks of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

ORIG AP for ICATIBANT (ICATIBANT)